1993
DOI: 10.1006/cimm.1993.1238
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Hyporesponsiveness in Human Lymphocytes-T Despite Their Expression of both the Co-receptor CD28 and Its Ligand B7

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1994
1994
1996
1996

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…We could therefore have missed the possible transient down-regulation of CD28 on CD4"ĉ ells. Secondly, the CD28 co-stimulatory pathway involves several other molecules such as CTLA-4 [32] and their ligands CD86 (B7-2) and CD80 (B7-1), which may also be involved in antigen-specific hyporesponsiveness. Indeed, antigen presentation in the absence of CD86/CD80 co-stimulation leads to T cell anergy [3,7].…”
Section: Discussionmentioning
confidence: 99%
“…We could therefore have missed the possible transient down-regulation of CD28 on CD4"ĉ ells. Secondly, the CD28 co-stimulatory pathway involves several other molecules such as CTLA-4 [32] and their ligands CD86 (B7-2) and CD80 (B7-1), which may also be involved in antigen-specific hyporesponsiveness. Indeed, antigen presentation in the absence of CD86/CD80 co-stimulation leads to T cell anergy [3,7].…”
Section: Discussionmentioning
confidence: 99%
“…The normal function of the CD28 molecule on T cells is to interact with its ligand, the B7 molecule, on antigen-presenting cells. When the T cell recognizes antigen via the T-cell antigen receptor, triggering of the CD28 molecule provides a costimulatory second signal which is required for activation (2,4). Stimulation of T cells via the antigen receptor in the absence of a secondary costimulatory signal such as CD28 results in T-cell anergy (15).…”
mentioning
confidence: 99%